Template:Seizure actively seizing management: Difference between revisions
Elcatracho (talk | contribs) |
|||
Line 15: | Line 15: | ||
*Secondary medications | *Secondary medications | ||
**ESETT trial<ref>[https://www.nejm.org/doi/10.1056/NEJMoa1905795 Kapur J, Elm J, Chamberlain J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. N Engl J Med. 2019;381(22):2103-2113. doi:10.1056/NEJMoa1905795]</ref> compared second line antiseizure medications and they all are equally efficacious. Therefore may be best to use the one with least side effects <ref>[https://emcrit.org/pulmcrit/esett/ PulmCrit- All 2nd line conventional anti-epileptics are equally good… or equally bad?]</ref> which is [[Levetiracetam]] | **ESETT trial<ref>[https://www.nejm.org/doi/10.1056/NEJMoa1905795 Kapur J, Elm J, Chamberlain J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. N Engl J Med. 2019;381(22):2103-2113. doi:10.1056/NEJMoa1905795]</ref> compared second line antiseizure medications and they all are equally efficacious. Therefore may be best to use the one with least side effects <ref>[https://emcrit.org/pulmcrit/esett/ PulmCrit- All 2nd line conventional anti-epileptics are equally good… or equally bad?]</ref> which is [[Levetiracetam]] | ||
**[[Levetiracetam]] IV 60 mg/kg, max 4500 mg/dose, or 1500 mg oral load (preferred in pregnancy) | **[[Levetiracetam]] IV 60 mg/kg, max 4500 mg/dose, or 1500 mg oral load <span style="color:#008000"> ('''preferred in pregnancy''')</span><ref>Macri E, Greene-Chandos D. Neurological Emergencies During Pregnancy. Neurol Clin. 2021 May;39(2):649-670. doi: 10.1016/j.ncl.2021.02.008. PMID: 33896537</ref> | ||
**[[Phenytoin]] IV 18 mg/kg at ≤ 50 mg/min | **[[Phenytoin]] IV 18 mg/kg at ≤ 50 mg/min <span style="color:red"> ('''avoid in pregnancy''')</span><ref>Macri E, Greene-Chandos D. Neurological Emergencies During Pregnancy. Neurol Clin. 2021 May;39(2):649-670. doi: 10.1016/j.ncl.2021.02.008. PMID: 33896537</ref> | ||
**[[Fosphenytoin]] IV 20-30 mg/kg at 150 mg/min (may also be given IM) | **[[Fosphenytoin]] IV 20-30 mg/kg at 150 mg/min (may also be given IM) | ||
***Contraindicated in pts w/ 2nd or 3rd degree AV block | ***Contraindicated in pts w/ 2nd or 3rd degree AV block | ||
***Avoid phenytoin or fosphenytoin in suspected toxicology case due to sodium channel blockade | ***Avoid phenytoin or fosphenytoin in suspected toxicology case due to sodium channel blockade | ||
**[[Valproic acid]] IV 20-40 mg/kg at 5 mg/kg/min, max 3000 mg (avoid in pregnancy) | **[[Valproic acid]] IV 20-40 mg/kg at 5 mg/kg/min, max 3000 mg <span style="color:red"> ('''avoid in pregnancy''')</span><ref>Macri E, Greene-Chandos D. Neurological Emergencies During Pregnancy. Neurol Clin. 2021 May;39(2):649-670. doi: 10.1016/j.ncl.2021.02.008. PMID: 33896537</ref> | ||
*Refractory medications | *Refractory medications | ||
**[[Propofol]] 2-5mg/kg, then infusion of 2-10mg/kg/hr '''OR''' | **[[Propofol]] 2-5mg/kg, then infusion of 2-10mg/kg/hr '''OR''' |
Latest revision as of 00:19, 21 October 2021
Seizure Precautions
- Protect patient from injury
- If possible, place patient in left lateral position to reduce risk of aspiration
- Do not place bite block!
- Jaw thrust, a NPA and oxygen may be required
- An IV line should be placed
Medications
- Benzodiazepine (Initial treatment of choice)[1]
- Midazolam IM 10 mg (> 40 kg), 5mg (13-40 kg), or 0.2 mg/kg[2]
- May also be given IN at 0.2 mg/kg, max 10 mg
- OR buccal at 0.3 mg/kg, max 10 mg
- Lorazepam IV 4 mg or 0.1 mg/kg; may repeat one dose[3]
- Diazepam IV 0.15-0.2 mg/kg (up to 10 mg); may repeat one dose or PR 0.2-0.5 mg/kg (up to 20 mg) once [4]
- Midazolam IM 10 mg (> 40 kg), 5mg (13-40 kg), or 0.2 mg/kg[2]
- Secondary medications
- ESETT trial[5] compared second line antiseizure medications and they all are equally efficacious. Therefore may be best to use the one with least side effects [6] which is Levetiracetam
- Levetiracetam IV 60 mg/kg, max 4500 mg/dose, or 1500 mg oral load (preferred in pregnancy)[7]
- Phenytoin IV 18 mg/kg at ≤ 50 mg/min (avoid in pregnancy)[8]
- Fosphenytoin IV 20-30 mg/kg at 150 mg/min (may also be given IM)
- Contraindicated in pts w/ 2nd or 3rd degree AV block
- Avoid phenytoin or fosphenytoin in suspected toxicology case due to sodium channel blockade
- Valproic acid IV 20-40 mg/kg at 5 mg/kg/min, max 3000 mg (avoid in pregnancy)[9]
- Refractory medications
- Propofol 2-5mg/kg, then infusion of 2-10mg/kg/hr OR
- Midazolam 0.2mg/kg, then infusion of 0.05-2mg/kg/hr OR
- Ketamine loading dose 0.5 to 3 mg/kg, followed by infusion of 0.3 to 4 mg/kg/hr[10]
- Lacosamide IV 400 mg IV loading dose over 15 min, then maintenance dose of 200 mg q12hrs PO/IV[11]
- Phenobarbital IV 15-20 mg/kg at 50-75 mg/min[12]
- Then continuous infusion at 0.5-4.0 mg/kg/hr
- Dose adjusted to suppression-burst pattern on continuous EEG
- Consider consulting anesthesia for inhaled anesthetics (potent anticonvulsants)[13]
- Others
- Carbamazepine 8 mg/kg oral suspension, single oral load
- Gabapentin 900 mg/day oral at 300 mg tid for 3 days
- Lamotrigine 6.5 mg/kg single oral load
Other Considerations
- Secondary causes of seizure (e.g. hyponatremia, hypoglycemia, INH toxicity, ecclampsia)
- Nonconvulsive seizures or status epilepticus - get EEG
- ↑ Glauser T, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016; 16(1):48-61.
- ↑ McMullan J, Sasson C, Pancioli A, Silbergleit R: Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: A meta-analysis. Acad Emerg Med 2010; 17:575-582
- ↑ Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48-61. doi:10.5698/1535-7597-16.1.48
- ↑ Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48-61. doi:10.5698/1535-7597-16.1.48
- ↑ Kapur J, Elm J, Chamberlain J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. N Engl J Med. 2019;381(22):2103-2113. doi:10.1056/NEJMoa1905795
- ↑ PulmCrit- All 2nd line conventional anti-epileptics are equally good… or equally bad?
- ↑ Macri E, Greene-Chandos D. Neurological Emergencies During Pregnancy. Neurol Clin. 2021 May;39(2):649-670. doi: 10.1016/j.ncl.2021.02.008. PMID: 33896537
- ↑ Macri E, Greene-Chandos D. Neurological Emergencies During Pregnancy. Neurol Clin. 2021 May;39(2):649-670. doi: 10.1016/j.ncl.2021.02.008. PMID: 33896537
- ↑ Macri E, Greene-Chandos D. Neurological Emergencies During Pregnancy. Neurol Clin. 2021 May;39(2):649-670. doi: 10.1016/j.ncl.2021.02.008. PMID: 33896537
- ↑ Legriel S, Oddo M, and Brophy GM. What’s new in refractory status epilepticus? Intensive Care Medicine. 2016:1-4.
- ↑ Legros B et al. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses. Neurocrit Care. 2014 Jun;20(3):484-8.
- ↑ Pugin D et al. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Critical Care 2014. DOI: 10.1186/cc13883.
- ↑ Mirsattari SM et al. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004 Aug;61(8):1254-9.